Ulcerative Colitis

In this Healio video, Marla Dubinsky, MD, chief of pediatric gastroenterology at Mount Sinai Kravis Children’s Hospital, discusses recent how to choose the right ulcerative colitis treatment for the right patient.

DENVER — Depression was associated with higher social vulnerability in individuals with inflammatory bowel disease and was largely influenced by socioeconomic and minority status, according to data at the Crohn’s and Colitis Congress.

Celltrion has submitted a biologics license application to the FDA for the consideration of a subcutaneous formulation of infliximab in the treatment of inflammatory bowel disease, according to a press release.

DENVER — In a Healio video exclusive, Alan Moss, MD, discusses his presentation at the Crohn’s and Colitis Congress, which detailed the use of therapeutic drug monitoring in the management of patients with inflammatory bowel disease.

DENVER — Providers should consider de-escalating combination therapy with immunomodulators to monotherapy after 1 year in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.

Individuals with a BMI of 30 kg/m² or more had an increased risk for colorectal cancer compared with individuals with normal weight, regardless of polygenic risk score, according to a study published in JAMA Network Open.

DENVER — In a Healio video exclusive, James D. Lewis, MD, MSCE, a gastroenterologist at the University of Pennsylvania Perelman School of Medicine, discusses what it might take to eventually cure or prevent inflammatory bowel disease.

DENVER — A varied and well-balanced diet plays “a significant role” in the management of patients with inflammatory bowel disease and can be guided with support from a dietitian, a presenter reported at the Crohn’s and Colitis Congress.

DENVER — Health care providers should apply cultural competency, sensitivity and humility when making dietary recommendations for patients with inflammatory bowel disease, noted a presenter at the Crohn’s and Colitis Congress.

DENVER — In a Healio video exclusive, Stefan D. Holubar, MD, MS, discusses the decades-long controversy surrounding preoperative use of biologics and risk for postoperative complications in patients with inflammatory bowel disease.